EUVIMEDEUVIMED entdecken
Crossref

Predictors of Malignancy and False‐Negative Risk in Large (≥ 3 cm) Thyroid Nodules: Insights From a Single‐Centre Thyroidectomy Cohort

Ömer Komaç iD, Elif Bilgili, Merve Yetişken, Deniz Çetin, Nesibe Kahraman Çetin, Ogün Aydoğan, Göksel Tuzcu, İmran Kurt Ömürlü, Mustafa Ünübol, Mustafa Gökhan Ünsal, Engin Güney

Clinical Endocrinology · 2026-12 · 105 (6) · 667-679

DOI: 10.1111/cen.70185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Endocrinology, online erschienen am 29.07.2026. Verfasst von Ömer Komaç und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Aydın Adnan Menderes University School of Medicine, Aydın, Türkiye. Hauptthemen laut MEDLINE: Thyroid Nodule, Thyroidectomy, Thyroid Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Whether nodule size compromises cytologic reliability remains controversial in managing large thyroid nodules. This study evaluated malignancy prevalence, predictors and false‐negative (FN) cytology in a surgical cohort enriched for nodules ≥ 3 cm.

Methods

We retrospectively analyzed 285 thyroidectomy patients (2018–2024) with a ≥ 3 cm dominant nodule. Each patient represented one analytic unit. The study assessed malignancy rates, clinical and imaging predictors, and FN risk among cytologically benign (Bethesda II) nodules. Demographic, biochemical and sonographic data—including nodule size, composition, EU‐TIRADS category and suspicious lymphadenopathy (LAP)—were retrieved from records. Multivariable logistic regression with bootstrap validation identified independent predictors of malignancy and factors linked to false negativity.

Results

Observed malignancy proportion was 13.3% in this thyroidectomy cohort (38/285), predominantly papillary carcinoma. Independent predictors: EU‐TIRADS TR4–5 (OR 7.6) and suspicious LAP (OR 6.0); size ≥ 4 cm (OR 2.6) and solid composition (OR 3.3) exerted smaller effects. Among 111 Bethesda II cases, postoperative malignancy occurred in five (4.5%), all in ≥ 4 cm nodules (7.5% vs. 0%; p = 0.023). Post hoc review of FN cases suggested cystic/infiltrative features potentially contributing to sampling limitations. Nodule size had a moderate association with FN probability (AUC 0.75).

Conclusions

In this surgically selected cohort of large thyroid nodules, sonographic risk, suspicious LAP and clinical context outperformed size alone in predicting malignancy. Even with benign cytology, nodules ≥ 4 cm with higher‐risk imaging or structural features may warrant repeat or targeted FNAB, core biopsy, or surgery, whereas lower‐risk phenotypes may still be considered for surveillance. These findings support a risk‐stratified, node‐informed approach beyond purely size‐driven surgery in surgically referred large nodules, although extrapolation to all large nodules in the general population should be made cautiously.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NoduleThyroidectomyThyroid NeoplasmsHumansFemaleRetrospective StudiesMiddle AgedMaleAdultFalse Negative ReactionsBiopsy, Fine-NeedleUltrasonographyAged

Stichwörter der Autor:innen

EU‐TIRADSfalse‐negative cytologyfine‐needle aspiration biopsylarge thyroid nodulesmalignancy predictors

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Aydın Adnan Menderes University School of Medicine, Aydın, Türkiye.
  • Department of Medical Pathology, Aydın Adnan Menderes University School of Medicine, Aydın, Türkiye.
  • Department of General Surgery, Aydın Adnan Menderes University School of Medicine, Aydın, Türkiye.
  • Department of Radiology, Aydın Adnan Menderes University School of Medicine, Aydın, Türkiye.
  • Department of Biostatistics, Aydın Adnan Menderes University School of Medicine, Aydın, Türkiye.
  • Private Practice, Aydın, Türkiye.

ORCID-Profile: Ömer Komaç

Zitieren

APA

Komaç, Ö., Bilgili, E., Yetişken, M., Çetin, D., Çetin, N. K., Aydoğan, O., Tuzcu, G., Ömürlü, İ. K., Ünübol, M., Ünsal, M. G., & Güney, E. (2026). Predictors of Malignancy and False‐Negative Risk in Large (≥ 3 cm) Thyroid Nodules: Insights From a Single‐Centre Thyroidectomy Cohort. Clinical Endocrinology, 105(6), 667-679. https://doi.org/10.1111/cen.70185

Vancouver

Komaç Ö, Bilgili E, Yetişken M, Çetin D, Çetin NK, Aydoğan O, et al. Predictors of Malignancy and False‐Negative Risk in Large (≥ 3 cm) Thyroid Nodules: Insights From a Single‐Centre Thyroidectomy Cohort. Clinical Endocrinology. 2026;105(6):667-679. doi:10.1111/cen.70185

BibTeX
@article{Koma2026,
  author = {Komaç, Ömer and Bilgili, Elif and Yetişken, Merve and Çetin, Deniz and Çetin, Nesibe Kahraman and Aydoğan, Ogün and Tuzcu, Göksel and Ömürlü, İmran Kurt and Ünübol, Mustafa and Ünsal, Mustafa Gökhan and Güney, Engin},
  title = {Predictors of Malignancy and False‐Negative Risk in Large (≥ 3 cm) Thyroid Nodules: Insights From a Single‐Centre Thyroidectomy Cohort},
  journal = {Clinical Endocrinology},
  year = {2026},
  volume = {105},
  number = {6},
  pages = {667--679},
  doi = {10.1111/cen.70185}
}
Kostenlos starten →